Search Results

• • 9 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Importance of Ethnicity, CYP2B6 and ABCB1 Genotype for Efavirenz Pharmacokinetics and Treatment Outcomes: A Parallel-Group Prospective Cohort Study in Two Sub-Saharan Africa Populations

  Authors:Eliford Ngaimisi, Abiy Habtewold, Omary Minzi, Eyasu Makonnen, Sabina Mugusi, Wondwossen Amogne, et al.From:PLoS ONE (Vol. 8, Issue 7) Peer-Reviewed

  July 5, 20136,847 words Clinical report 1550LObjectives We evaluated the importance of ethnicity and pharmacogenetic variations in determining efavirenz pharmacokinetics, auto-induction and immunological outcomes in two African populations. Methods ART...

• Comparison of N-acetyltransferase-2 enzyme genotype-phenotype and xanthine oxidase enzyme activity between Swedes and Koreans

  Authors:Natasa Djordjevic, Juan Antonio Carrillo, Hyung-Keun Roh, Sara Karlsson, Nobuhisa Ueda, Leif Bertilsson, et al.From:Journal of Clinical Pharmacology (Vol. 52, Issue 10) Peer-Reviewed

  Oct. 2012 Report

   Citation Only

• Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: a prospective cohort study

  Authors:Hanna Nylen, Abiy Habtewold, Eyasu Makonnen, Getnet Yimer, Leif Bertilsson, Jurgen Burhenne, et al.From:Medicine (Vol. 95, Issue 34) Peer-Reviewed

  Aug. 23, 2016 Article

   Citation Only

• Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study.

  Authors:Hanna NylȨn, Abiy Habtewold, Eyasu Makonnen, Getnet Yimer, Leif Bertilsson, Jȭrgen Burhenne, et al.From:Medicine (Vol. 95, Issue 32) Peer-Reviewed

  Aug. 1, 2016423 words Report, Author abstr...

   Abstract Only

• Is there a need to increase the dose of efavirenz during concomitant rifampicin-based antituberculosis therapy in sub-Saharan Africa? The HIV-TB pharmagene study

  Authors:Abiy Habtewold, Eyasu Makonnen, Wondwossen Amogne, Getnet Yimer, Getachew Aderaye, Leif Bertilsson, et al.From:Pharmacogenomics (Vol. 16, Issue 10) Peer-Reviewed

  July 20159,462 words Report 1810LAuthor(s): Abiy Habtewold aff1 aff2 , Eyasu Makonnen aff2 , Wondwossen Amogne aff3 aff4 , Getnet Yimer aff1 aff2 , Getachew Aderaye aff3 , Leif Bertilsson aff1 , Jürgen Burhenne aff5 , Eleni Aklillu [*] aff1 Keywords...

• Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

  Authors:Inger Johansson, Eva Lundqvist, Leif Bertilsson, Marja-Liisa Dahl, Folke Sjoqvist, and Magnus Ingelman-SundbergFrom:Proceedings of the National Academy of Sciences of the United States (Vol. 90, Issue 24) Peer-Reviewed

  Dec. 15, 199363 words Article

   Abstract Only

• CYP2D6, serotonin and suicide

  Authors:Johan Ahlner, Anna-Lena Zackrisson, Bertil Lindblom, and Leif BertilssonFrom:Pharmacogenomics (Vol. 11, Issue 7) Peer-Reviewed

  July 20101,747 words Editorial 1310LAuthor(s): Johan Ahlner [[dagger]] 1 , Anna-Lena Zackrisson 2 , Bertil Lindblom 3 , Leif Bertilsson 4 Major depressive disorder (MDD) is common, and suicide is a public health issue and an important cause of early...

• D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate

  Authors:Svante Nybert, Lars Farde, Christer Halldin, Marja-Liisa Dahl, and Leif BertilssonFrom:American Journal of Psychiatry (Vol. 152, Issue 2) Peer-Reviewed

  Feb. 1995204 words Article

   Abstract Only

• CSF 5-HIAA predicts suicide risk after attempted suicide

  Authors:Peter Nordstrom, Mats Samuelsson, Marie Asberg, Lil Traskman-Bendz, Anna Aberg-Wistedt, Conny Nordin, et al.From:Suicide and Life-Threatening Behavior (Vol. 24, Issue 1) Peer-Reviewed

  Spring 1994157 words Article

   Abstract Only